GSK admits papers were fraudulent but researchers escape unscathed
When GlaxoSmithKline agreed to pay a record-setting $3 billion fine last month, it admitted that the notorious Study 329 was part of the fraud. Why won't Brown University take action against the researcher? Why won't the journal that published the study retract it? Read about it in The Chronicle of Higher Education.